Current Date/Time *

• linkId: CurrentDate

Current date/time

• linkId: CurrentDateTime_helpText

Date Review Performed *

• linkId: ReviewDate

The date that the review was performed

• linkId: ReviewDate_helpText

CASE DEFINITION The transition from PCR to RATs as a primary mode of testing requires the clinical criteria to be applied thoughtfully and practically alongside the Case Definition. The case definitions were based upon PCR tests being the primary mode of diagnosis and the focus has now changed to clinical decision making based on a RAT result in the majority of cases. Clinical discretion should be applied to household contacts who test negative by RAT but are presenting with symptoms typical of COVID-19 infection. Although this population is not defined by the Case Definition^, clinical discretion may support recognition as a likely case and initiation of treatment, where indicated. ^For definition see https://www.tewhatuora.govt.nz/for-the-health-sector/covid-19-information-for-health-professionals/case-definition-and-clinical-testing-guidelines-for-covid-19#:~:text=Case%20definitions&text=A%20case%20that%20has%20laboratory,a%20validated%20NAAT%20(PCR)

• linkId: case-definition-panel

Is the patient a COVID-19 case as per the case definition or clinical criteria? *

• linkId: COVID19-Positive
• Initial Values: false

Does the patient meet the current Pharmac criteria for COVID-19 Antivitals?

• linkId: criteria-panel

1. Symptoms started: * ??

• linkId: SymptomsStart
• Answers: https://nzhts.digital.health.nz/fhir/ValueSet/antiviral-eligibility-symptoms-started

2. My patient requires supplemental oxygen *

• linkId: supoxygen

3. My patient's condition or circumstance (choose one): * ??

• linkId: criteria
• Answers: https://nzhts.digital.health.nz/fhir/ValueSet/COVID19-antiviral-eligibility-criteria

[1]For definition of Ministry of Health criteria of ‘severe immunocompromise’ for third primary dose see: https://www.health.govt.nz/covid-19-novel-coronavirus/covid-19-vaccines/covid-19-vaccine-severely-immunocompromised-people#criteria [2]A primary dose for most people is 2 vaccinations [3]For Ministry of Health's definition of high-risk conditions see https://covid19.govt.nz/testing-and-isolation/if-you-have-covid-19/medicines-to-treat-covid-19/

• linkId: myPatientCriteria_helpText

Assessment: No - the patient IS NOT eligible for COVID-19 Antivirals

Answer options for eligible-no

• null#null ("confirm")

??

• linkId: eligible-no
• Enable When: todo
• Answers: 1 option

Assessment: Yes - the patient IS eligible for COVID-19 Antivirals

Answer options for eligible-yes

• null#null ("confirm")

??

• linkId: eligible-yes
• Enable When: todo
• Answers: 1 option

Please provide pharmacist details

• linkId: PharmacistInformation

Pharmacist Name *

• linkId: PharmacistName

Pharmacist ID *

• linkId: PharmacistID

Please provide details about the pharmacy organisation

• linkId: PharmacyInformation

Pharmacy Name *

• linkId: PharmacyName

Pharmacy HPI *

• linkId: PharmacyHPI

Pharmacy address details

• linkId: PharmacyAddress

Please provide details about the patient's general practice

• linkId: GeneralPracticeInformation

GP Practice Name

• linkId: GPName

Practice EDI

• linkId: GPEDI

Send note to GP Inbox?

• linkId: SendToGP
• Initial Values: false

It may not be necessary to send this message. Please consider if clinically-relevant before sending.

• linkId: SendToGP_helpText